Cargando…
Comparative palatability of orally disintegrating tablets (ODTs) of Praziquantel (L-PZQ and Rac-PZQ) versus current PZQ tablet in African children: A randomized, single-blind, crossover study
BACKGROUND: Praziquantel (PZQ) is currently the only recommended drug for infection and disease caused by the schistosome species that infects humans; however, the current tablet formulation is not suitable for pre-school age children mainly due to its bitterness and the large tablet size. We assess...
Autores principales: | Mahende, Muhidin K., Huber, Eric, Kourany-Lefoll, Elly, Ali, Ali, Hayward, Brooke, Bezuidenhout, Deon, Bagchus, Wilhelmina, Kabanywanyi, Abdunoor M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216518/ https://www.ncbi.nlm.nih.gov/pubmed/34106922 http://dx.doi.org/10.1371/journal.pntd.0007370 |
Ejemplares similares
-
Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis
por: Bustinduy, Amaya L., et al.
Publicado: (2016) -
Morphological Characteristics of Schistosoma mansoni PZQ-Resistant and -Susceptible Strains Are Different in Presence of Praziquantel
por: Pinto-Almeida, António, et al.
Publicado: (2016) -
The Anthelmintic
Activity of Praziquantel Analogs
Correlates with Structure–Activity Relationships at TRPM(PZQ) Orthologs
por: Sprague, Daniel J., et al.
Publicado: (2023) -
Relative Bioavailability of Orally Dispersible Tablet Formulations of Levo‐ and Racemic Praziquantel: Two Phase I Studies
por: Bagchus, Wilhelmina Maria, et al.
Publicado: (2018) -
Activation of transient receptor potential channel Sm.(Schistosoma mansoni)TRPM(PZQ) by PZQ, enhanced Ca(++) influx, spastic paralysis, and tegumental disrupture—the deadly cascade in parasitic schistosomes, other trematodes, and cestodes
por: Harder, Achim
Publicado: (2020)